The combined efforts of Atropos Health and Guidehouse have resulted in a new clinical decision support (CDS) point-of-care solution that seeks to assist life science companies in incorporating real-world evidence (RWE) in their clinical workflow processes. The recently unveiled solution is a product of the partnership between Atropos Health’s predictive modeling, evidence generation, and large evidence library, and the commercialization and advisory services of Guidehouse, which will help healthcare providers make better diagnoses and treatment decisions at the point of care. The solution is designed to be used in electronic health records (EHR) systems and allows healthcare practitioners to define patient population groups and use evidence-based information in real time to make treatment decisions using the closed-loop CDS model.
Also Read: Charles River Advances AI-Driven Digital Pathology to Accelerate Drug Research
The company Atropos Health claims that its ecosystem is comprised of GENEVA OS®, Alexandria®, and evidence generation tools including ChatRWD®, Green Button®, and Atropos Evidence™ Agent, all of which contribute to the acceleration of evidence-based medicine and personalization of healthcare. This launch is seen as yet another manifestation of the increasing importance of real-world data and AI for life sciences, where companies aim to find better solutions to accelerate the process of improving patient outcomes, facilitate clinical decision making, and implement their drug development strategies. Guidehouse, a company that works in both commercial and government sectors, adds strategic consulting, technology integration, and managed services expertise to the new collaboration. As for industry experts, the launch of the collaboration is seen as yet another step towards embedding AI-powered evidence generation into routine healthcare. In addition, the company’s launch can be viewed as a new step towards reinforcing Atropos Health’s growing position in the healthcare AI and real-world evidence market.
